#Keytruda

Hidden Small Caps

hiddensmallcaps

More on this news for $PSNL and checkpoint inhibitors. I'll do my best to explain but I'm not a scientist and defer to experts. Here's the link:https://investors.personalis.com/news-releases/news-release-details/personalis-annou

Pashtoon Kasi MD, MS

pashtoonkasi

Another agnostic approval.#Pembrolizumab #TMBTMB cutoff >=Though I’m overall very supportive of agnostic approvals overall, not sure if TMB is the same across tissue types. @US_FDA #OncoAlert #PrecisionMedicine https://seekingalpha.com

Shrey Srivastava

BlogShrey

#DDDD $DDDD $LBPS $LOACA very promising RNS today.Bit by bit analysis below. #DDDD $DDDD $LBPS $LOAC'We have generated additional safety and efficacy data, building on the positive data from both

Matt

MattBiotech

$PDSB - PDS Biotech has a platform focused on encapsulating antigens in positively charged lipids which are taken up by dendritic cells and presented to CD4 and CD8 killer T

Chris Randone

ChrisRandone

Tomorrow the market is back open. How things might look for our beloved $KTOV & with Q2 ending Tuesday, will partnerships be announced? Is there really a buyout in play?

The Chief Who

WalksWithBulls

Ok everyone a lot has happen here in the last few days & it’s been a wild ride for team $ktov with much going on and speculation growing througout... I’ve

High Point Investing

HighPointInvest

$LOAC - SPAC for 4D Pharma (#DDDD) due diligence thread including:Company overviewProduct overview Collaborations with major #pharma companies ( $MRK, $PFE, and Merck KGaA)Key competitorsPipeline and upcoming catalysts 𝘾𝙤𝙢𝙥𝙖

WarrenPuffett

warrenpuffettt

$LOAC Thread: My new swing that I will be holding through January. This is my favorite non EV SPAC for many reasons A little background: $LOAC is merging with @4dpharmaplc

Shrey Srivastava

BlogShrey

While looking at speculative pharmaceutical stocks I am reminded of why I am averse to these risky picks.#DDDD was compelling enough, though, to break this rule. The 10+ treatments under

Ambulatus

ambulatus

$RAC.AX #asx #oncology #cancer@RaceOncology could be a 2021 #asx 10+ baggerWhy follows in this thread. First watch the strategy video./1https://www.youtube.com/watch?v=J7WKOtMEPnI Bisantrene was shown decades ago to be safe and effective

Shrey Srivastava

BlogShrey

#DDDD $DDDD $LBPS $LOAChttps://www.genengnews.com/news/merck-co-launches-up-to-2-5b-cancer-collaboration-with-taiho-astex/More Merck $MRK news that bodes very well for 4d Pharma, specifically in (immuno-)oncology. 'Merck & Co. said

Shrey Srivastava

BlogShrey

#DDDD $DDDD $LBPS $LOACMRx0518 seems to be the gift that keeps on giving right now!The 'clinical trial collaboration and supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer' is fantastic

Game Changer Capital (John)

gamechangercap

$NVCR A on why I have been buying since late 2016 and think the SP could go to $500. In 2000 Yoram Palti created a new cancer treatment based on

Hardy AIM 🎯

AimHardy

#DDDD $LBPS 4D Pharma Oncology Update MRx0518 continues to show great promise for a blanket potential treatment across every cancer indication trailed to date, restoring the optimal function of patients

Hardy AIM 🎯

AimHardy

I have substantially bought #DDDD today I have done extensive research into #COVID19 treatments companies listed on AIM over the weekend (Around 30 HOURS) and came to the conclusions DDDD

Shrey Srivastava

BlogShrey

#DDDD $LBPS $LOACA thread on the potential near term catalysts behind why I have increased my position in 4d Pharma @4dpharmaplc (LON: #DDDD): 1) NASDAQ listing. This is the most

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.